Barry Iacopetta
Roche (Switzerland)(CH)Novartis (Switzerland)(CH)Johnson & Johnson (United States)(US)Bristol-Myers Squibb (Germany)(DE)University of Western Australia(AU)Pfizer (United States)(US)Ipsen (France)(FR)Sir Charles Gairdner Hospital(AU)Puma Biotechnology (United States)(US)Merck (Singapore)(SG)
Publications by Year
Research Areas
Genetic factors in colorectal cancer, Colorectal Cancer Screening and Detection, Colorectal Cancer Treatments and Studies, Cancer Genomics and Diagnostics, Epigenetics and DNA Methylation
Most-Cited Works
- → Tumor-Infiltrating FOXP3 + T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer(2008)969 cited
- → Are there two sides to colorectal cancer?(2002)789 cited
- → Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR(2002)608 cited
- → Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer(2000)557 cited
- → The TP53 Colorectal Cancer International Collaborative Study on the Prognostic and Predictive Significance of p53 Mutation: Influence of Tumor Site, Type of Mutation, and Adjuvant Treatment(2005)414 cited
- → TP53 mutation in colorectal cancer(2003)339 cited